Edition:
India

Insider Trading: Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

31.10USD
17 Sep 2019
Change (% chg)

-- (--)
Prev Close
$31.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
149,194
52-wk High
$41.59
52-wk Low
$18.00

All Insider Trades
Trading Date Name Title Type Shares Traded Price
15 Jul 2019

Conner (Edward R)

Officer Buy 30,000 $0.00
24 Jun 2019

Lange (Louis G)

Director Sell 3,602 $38.15
24 Jun 2019

Lange (Louis G)

Director Sell 200 $39.46
24 Jun 2019

Lange (Louis G)

Director Sell 800 $37.89
24 Jun 2019

Lange (Louis G)

Director Sell 600 $40.00
24 Jun 2019

Lange (Louis G)

Director Sell 15,798 $37.60
5 Jun 2019

Prasad (Suyash)

Officer Sell 757 $37.31
5 Jun 2019

Soloway (Thomas P)

Chief Financial Officer Sell 1,009 $37.31
5 Jun 2019

Holles Natalie C

President Sell 1,009 $37.31
5 Jun 2019

Patterson (Matthew R)

Chief Executive Officer Sell 3,332 $37.31
13 May 2019

Prasad (Suyash)

Officer Sell 54 $37.72
13 May 2019

Prasad (Suyash)

Officer Buy 10,000 $0.79
13 May 2019

Prasad (Suyash)

Officer Sell 9,946 $36.98
28 Mar 2019

Meltz (Mark A.)

General Counsel Buy 37,333 $0.00
25 Mar 2019

Lange (Louis G)

Director Sell 19,700 $35.99
25 Mar 2019

Lange (Louis G)

Director Sell 558 $35.94
25 Mar 2019

Lange (Louis G)

Director Sell 300 $36.64
25 Mar 2019

Lange (Louis G)

Director Sell 1,000 $36.00
25 Feb 2019

Patterson (Matthew R)

Chief Executive Officer Sell 4,000 $30.00
25 Feb 2019

Patterson (Matthew R)

Chief Executive Officer Buy 4,000 $2.19
25 Feb 2019

Patterson (Matthew R)

Chief Executive Officer Sell 17,000 $30.00
25 Feb 2019

Patterson (Matthew R)

Chief Executive Officer Buy 17,000 $0.78
25 Feb 2019

Prasad (Suyash)

Officer Sell 10,000 $30.06
25 Feb 2019

Prasad (Suyash)

Officer Buy 10,000 $0.79
6 Feb 2019

Prasad (Suyash)

Officer Buy 17,500 $0.00

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 206
Total Shares Held: 45,817,083
3 Mo. Net Change: -251,227
# New Positions: 8
# Closed Positions: 4
# Increased Positions: 15
# Reduced Positions: 13
# Net Buyers: 2

Officers & Directors

Name Age Since Current Position

Matthew Patterson

47 2018 Chairman of the Board, Chief Executive Officer

Natalie Holles

46 2018 President, Chief Operating Officer

Thomas Schuetz

58 2013 Co-Founder, Independent Director

Thomas Soloway

52 2019 Chief Financial Officer, Executive Vice President

Mark Meltz

45 2019 Senior Vice President, General Counsel

David Nagler

66 2015 Senior Vice President - Human Resources and Corporate Affairs

Edward Conner

45 2019 Senior Vice President and Chief Medical Officer

Fulvio Mavilio

2019 Senior Vice President - Translational Science

Eric Mosbrooker

52 2019 Senior Vice President and Chief Commercial Officer

Mary Newman

59 2014 Senior Vice President - Regulatory Affairs

Sarah Spencer

2019 Vice President, Corporate Communications

Louis Lange

70 2018 Lead Independent Director

Mark Goldberg

64 2017 Independent Director

Jennifer Jarrett

48 2017 Independent Director

Scott Morrison

61 2015 Independent Director

Julie Smith

48 2016 Independent Director

Andrew Chang

Director, Investor Relations